Brian Irving represents businesses and individuals in complex litigation and government investigations, focusing on controlled substances and diversion, healthcare fraud, and high-stakes commercial disputes. His clients span a variety of industries, including healthcare, pharmacy, government contracting, and financial services. Brian has successfully represented clients in federal and state courts at both the trial and appellate levels, and in arbitrations and other forms of alternative dispute resolution.
Brian’s practice includes:
- Controlled Substances & Diversion – As co-chair of the Controlled Substances and Diversion practice, Brian advises Drug Enforcement Administration (DEA) registrants nationwide on compliance matters and government investigations and enforcement actions related to the Controlled Substances Act (CSA), Food, Drug, and Cosmetic Act (FD&C Act), and related federal and state drug laws.
- Healthcare Fraud & Abuse – Defends healthcare providers in False Claims Act litigation and investigations by the U.S. Department of Justice, United States Attorneys’ Offices, and HHS-OIG, including for alleged violations of the Anti-Kickback Statute and Stark Law.
- Business Disputes – Represents businesses and individuals in complex commercial litigation involving breach of contract, torts, shareholder and fiduciary disputes, earnout disagreements, and alleged violations of federal and state securities laws.
Brian is the editor of the firm’s Inside the False Claims Act blog.
Prior to joining Bass, Berry & Sims, Brian clerked for the Honorable Bobby E. Shepherd on the U.S. Court of Appeals for the Eighth Circuit. Brian earned his law degree from Vanderbilt Law School where he was elected to the Order of the Coif and served as an Articles Editor on the Vanderbilt Law Review. He received a B.A. in philosophy from Yale University. Before law school, Brian played professional baseball in the San Francisco Giants organization.
